Roche Holdings AG received CE mark approval for the integration of its artificial intelligence-enabled continuous glucose ...

When Robert Kennedy Jr. announced the cancellation of 22 projects related to mRNA vaccines and the end of new investments in ...

People have some inability to focus on [Regeneron Pharmaceuticals Inc.’s] pipeline,” which stands as “the most prolific in the industry, I would dare to say,” CEO Leonard Schleifer remarked during the ...

For enquiring minds that want to know, Susan Monarez laid out the details Sept. 17 of how she was fired as CDC director for the Senate Health, Education, Labor and Pensions Committee.

Japan’s Pharmaceuticals and Medical Devices Agency has traditionally been less than receptive to clinical data from other ...

Three-year-old Areteia Therapeutics Inc. hit the primary endpoint in its Exhale-4 phase III study of dexpramipexole for ...

Recent comments from CDER Director George Tidmarsh suggesting that the agency may be backing away from the use of its ...

On the heels of the announcement of German bionics developer Ottobock SE KGaA's pending IPO and more than 20 med-tech IPOs ...

Dualitas Therapeutics Inc. exited stealth mode with a $65 million series A investment that was co-led by Versant Ventures and ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accurkardia, Bar-Ilan University, Clearcam, Co-Diagnostics, Collplant, Genesee, Highridge ...

The U.S. Federal Trade Commission has posted notice to health care companies that their use of noncompete agreements for physicians and nurses may violate the law. The advisory may allow physicians ...

Biocartis Group NV received premarket approval from the U.S. FDA for its Idylla Cdx MSI test, developed in partnership with Bristol Myers Squibb Co., to help in the diagnosis and treatment of ...